Introduction Tumour deposits (TDs) are an important prognostic marker in colorectal cancer. However, the classification, and inclusion in staging, of TDs has changed significantly in each TNM Edition since their initial description in TNM 5, and terminology remains controversial. Expert consensus is needed to guide the future direction of precision staging. Methods A modified Delphi consensus process was used. Statements were formulated and sent to participants as an online survey. Participants were asked to rate their agreement with each statement on a 5‐point Likert scale and also to suggest additional statements for discussion. These responses were circulated, together with anonymised comments, and statements were modified prior to ...
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet ...
Objective: To investigate whether tumor deposits (TDs) in rectal cancer are associated withincreased...
Background. The prognostic value of tumor deposit (TD) count in colorectal cancer (CRC) patients has...
AIMS: Tumour deposits (TDs) are an important prognostic marker in colorectal cancer. However, the cl...
International audienceThe management of colorectal cancer (CRC) highly relies on the TNM staging sys...
Contains fulltext : 174850pub.pdf (publisher's version ) (Open Access)Purpose Colo...
PURPOSE: New editions of the TNM staging system for colorectal cancer have been subject to extensive...
PURPOSE: Colorectal cancer (CRC) treatment is largely determined by tumor stage. Despite improvement...
Aims The presence and significance of extranodal tumour deposits (ENTDs) in colorectal cancer (CRC) ...
8The seventh edition of the TNM Classification of Malignant Tumors is due to be published soon. In t...
OBJECTIVE: The 7th edition of AJCC staging manual implicitly states that only T1 and T2 lesions that...
The 7th edition of AJCC staging manual implicitly states that only T1 and T2 lesions that lack regio...
Context.-Colorectal cancer is the leading cause of morbidity and death among gastrointestinal tumors...
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet ...
Traditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer pa...
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet ...
Objective: To investigate whether tumor deposits (TDs) in rectal cancer are associated withincreased...
Background. The prognostic value of tumor deposit (TD) count in colorectal cancer (CRC) patients has...
AIMS: Tumour deposits (TDs) are an important prognostic marker in colorectal cancer. However, the cl...
International audienceThe management of colorectal cancer (CRC) highly relies on the TNM staging sys...
Contains fulltext : 174850pub.pdf (publisher's version ) (Open Access)Purpose Colo...
PURPOSE: New editions of the TNM staging system for colorectal cancer have been subject to extensive...
PURPOSE: Colorectal cancer (CRC) treatment is largely determined by tumor stage. Despite improvement...
Aims The presence and significance of extranodal tumour deposits (ENTDs) in colorectal cancer (CRC) ...
8The seventh edition of the TNM Classification of Malignant Tumors is due to be published soon. In t...
OBJECTIVE: The 7th edition of AJCC staging manual implicitly states that only T1 and T2 lesions that...
The 7th edition of AJCC staging manual implicitly states that only T1 and T2 lesions that lack regio...
Context.-Colorectal cancer is the leading cause of morbidity and death among gastrointestinal tumors...
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet ...
Traditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer pa...
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet ...
Objective: To investigate whether tumor deposits (TDs) in rectal cancer are associated withincreased...
Background. The prognostic value of tumor deposit (TD) count in colorectal cancer (CRC) patients has...